NOAEL Studies
Cosmetic Ingredient
Calcium Aspartate NOAEL Studies
INCI: CALCIUM ASPARTATE
CAS: 21059-46-1
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
EFSA 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| EFSA | NOAEL | =700 | mg/kg bw/day | Rat | oral: feed | 90 days | subchronic | EFSA ANS - 2008 - OutputID 558 - histopathology neoplastic - nephrotoxicity - Magnesium aspartate, potassium aspartate, magnesium potassium aspartate, calcium aspartate, zinc aspartate, and copper aspartate as sources for magnesium, potassium, calcium, zinc, and copper added for nutritional purposes to food supplements - doi:10.2903/j.efsa.2008.883 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 09U1335X8K | UNII | - | - | - | chemical | - |